Loading…
ADCT
ADC Therapeutics SA
NYSE· Healthcare· Drug Manufacturers - Specialty & Generic· CUSIP H0036K147
$1.40-6.04%Price as of Oct 17, 12:02 UTC · updated once a day, after the close
At a glance
ADC Therapeutics SA (ADCT) is listed on NYSE and classified in Drug Manufacturers - Specialty & Generic, part of the Healthcare sector. It is headquartered in Epalinges, Switzerland and has 188 employees. The company is worth $178.73M. Revenue was $81.36M in fiscal 2025, up 14.9% from the year before. It reported a net loss of $142.62M. The share price is 71.9% below its 52-week high of $4.98. 5 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Steve Cohen (Point72 Asset Management), at $3.9M. In that quarter, 1 of them opened or added to the position. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $178.73M
- P/E
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.00%
- Payout
- —
- EPS
- -$0.60
- ROE
- —
- Profit margin
- -121.77%
- Revenue growth
- +2.20%
- Beta
- 1.86
- 52-week high
- $4.98
- 52-week low
- $0.78
History
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -93.7% over 5Y.
today you would have $48.29▼ -95.2%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 4 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $3.53 | $1.99 | $1.66 | $3.84 | |
| P/S | 2.4x | 5.5x | 2.8x | 2.0x | 1.5x |
| P/B | — | — | — | — | 3.9x |
| EPS | -$1.12 | -$1.62 | -$2.94 | -$2.01 | |
| Profit margin | -199.07% | -175.31% | -222.83% | -345.11% |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| ACOGAlpha Cognition Inc. | $8.19 | — | 3.4x | 0.00% | -49.53% | $178.36M |
| IVVDInvivyd, Inc. | $0.61 | — | 1.0x | 0.00% | -95.89% | $179.83M |
| KRROKorro Bio, Inc. | $12.05 | — | 1.7x | 0.00% | -97.69% | $177.44M |
| ELDNEledon Pharmaceuticals, Inc. | $2.13 |
About the company
- 188
- Epalinges, Switzerland